Techlife Capital is a Paris-based growth equity firm founded in 2018. The firm specializes in making growth buy-out investments in companies within the healthcare and technology sectors. By focusing on these industries, Techlife Capital aims to support the development and expansion of innovative businesses that contribute to advancements in health and technology.
Flash Therapeutics is a gene therapy company focused on developing innovative gene and cell-based therapies through its proprietary lentiviral platform. The company specializes in the manufacture of gene transfer tools, which are essential for creating cellular and animal models used in validating candidate genes and conducting drug screenings. By producing highly concentrated and purified viral vectors, Flash Therapeutics enhances its ability to develop predictive experimental cellular models and genetically modified animals. Its approach incorporates both patented non-integrative technology and integrative lentiviral vectors, positioning the company at the forefront of advancements in gene therapy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.